ArticleEndocrine2020
Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease.
Lejia Sun et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it